Merck Animal Health launches Innovax®-ILT-IBD vaccine to guard against three poultry viruses

Merck Animal Health* has introduced Innovax®-ILT-IBD, a vaccine that provides combined protection and immunization against Marek’s disease (MD), infectious laryngotracheitis (ILT) and infectious bursal disease (IBD) in a single injection.

It can be administered in the hatchery to layers and breeder flocks to increase early-life protection, and to broilers, both by subcutaneous injection at day-old or in ovo application at 18 days of incubation.

Building on Merck Animal Health’s legacy of protection offered by Innovax-ILT, Innovax -ILT-IBD features two glycoprotein inserts instead of one and provides twice the protection against ILT, in addition to the IBD antigen.

The company says the unique combination of two glycoproteins (gD and gl) ensures a robust cellular immune response and a neutralizing antibody response.

Demonstrated protection

“Merck Animal Health continues to shape the future of animal health by developing innovative, science-driven ways to preserve poultry health and performance while maximizing our customers’ productivity,” said Charles Broussard, DVM, senior account manager for poultry sales, Merck Animal Health.

“In commercial poultry farming, viral infections can lead to significant economic losses if flocks are not sufficiently protected through vaccinations as pathogens can spread rapidly among birds. Innovax -ILT-IBD provides protection against three of the most common viruses that affect poultry flocks.”

Vaccination with Innovax-ILT-IBD in the hatchery provides scientifically demonstrated protection as early as 5 days for MD, 14 days for IBD and 28 days for ILT.

Innovax-ILT-IBD is available in a 2,000-dose ampoule. For more information about Innovax-ILT-IBD, contact your Merck Animal Health sales or technical services representative or click here.

*Merck Animal Health is known as MSD Animal Health outside the US and Canada.

 

Merck Animal Health introduces INNOVAX-ILT-IBD, a vaccine that provides combined protection against Marek’s disease (MD), infectious laryngotracheitis (ILT) and infectious bursal disease (IBD) in a single injection providing immunization against all three viruses.

 

 

 

Editor’s note: Content on Modern Poultry’s Industry Insights pages is provided and/or commissioned by our sponsors, who assume full responsibility for its accuracy and compliance.

Posted on: February 12, 2024

post it

Merck Animal Health* has introduced Innovax®-ILT-IBD, a vaccine that provides combined protection and immunization against Marek’s disease (MD), infectious laryngotracheitis (ILT) and infectious bursal disease (IBD) in a single injection.

It can be administered in the hatchery to layers and breeder flocks to increase early-life protection, and to broilers, both by subcutaneous injection at day-old or in ovo application at 18 days of incubation.

#poultryproduction #poultryhealth

RELATED CONTENT

Modern Poultry is pleased to host
this editorial page on behalf of

Merck Animal Health